Verapamil and cyclosporin A modulate doxorubicin toxicity by distinct mechanisms

This publication has 13 references indexed in Scilit:

• Chemosensitisation by verapamil and cyclosporin A in mouse tumour cells expressing different levels of P-glycoprotein and CP22 (sorcin)
  British Journal of Cancer, 1990
• Improved cellular accumulation is characteristic of anthracyclines which retain high activity in multidrug resistant cell lines, alone or in combination with verapamil or cyclosporin A
  Biochemical Pharmacology, 1989
• Effects of cyclosporin a and verapamil on the intracellular daunorubicin accumulation in chinese hamster ovary cells with increasing levels of drug‐resistance
  International Journal of Cancer, 1989
• Effect of cyclosporin A on daunorubicin accumulation in multidrug-resistant P388 leukemia cells measured by real-time flow cytometry
  Cancer Chemotherapy and Pharmacology, 1989
• Reduced cyclosporin accumulation in multidrug-resistant cells
  Biochemical and Biophysical Research Communications, 1988
• Modification of cytotoxic drug resistance by non-immuno-suppressive cyclosporins
  British Journal of Cancer, 1988
• The cell biology of multiple drug resistance
  Biochemical Pharmacology, 1987
• Cyclosporin A corrects daunorubicin resistance in Ehrlich ascites carcinoma
  British Journal of Cancer, 1986
• Cyclosporin A reverses vincristine and daunorubicin resistance in acute lymphatic leukemia in vitro.
  Journal of Clinical Investigation, 1986
• Factors governing the modulation of vinca-alkaloid resistance in doxorubicin-resistant cells by the calmodulin inhibitor trifluoperazine
  Biochemical Pharmacology, 1986